Team Finds New Way to Map Important Drug Targets

Innovative techniques from the Cherezov lab and new X-ray technology have enabled faster, more accurate imaging of hard-to-study membrane proteins, in this case the human serontin receptor.

Scientists Design Targeted New Drug Candidates Based on Detailed Picture of Muscular Dystrophy Defect

Researchers from the Disney lab have designed compounds that, even in small amounts, have the potential to counter defects associated with myotonic dystrophy type 2—and reverse the disease.

Nociceptin: Nature’s Balm for the Stressed Brain

The Roberto lab shows the brain’s own anti-stress system can prevent and even reverse some cellular effects of acute stress.

Researchers Identify Possible Key to Drug Resistance in Crohn’s Disease

Scientists from the Sundrud lab have identified a normally small subset of immune cells that may play a major role in the development of Crohn’s disease as well as steroid resistance associated with the disease.